$ALT
Altimmune, Inc. Stock $alt

$alt Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-Q Financial Statement

#000119312517338977 Filed on November 09, 2017

Income Statement

Concept	2017 Q4	2017 Q3	2016 Q3
Revenue	$2.810M	$4.592M	$901.0K
YoY Change	160.19%	409.63%	-22.32%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.590M	$3.040M	$3.290M
YoY Change	-11.67%	-7.6%	167.48%
% of Gross Profit
Research & Development	$4.460M	$5.906M	$2.401M
YoY Change	87.39%	145.97%	113.25%
% of Gross Profit
Depreciation & Amortization	$40.00K	$30.00K	$32.24K
YoY Change	100.0%	-6.93%	-7.91%
% of Gross Profit
Operating Expenses	$6.050M	$35.54M	$5.691M
YoY Change	44.74%	524.62%	102.2%
Operating Profit		-$30.95M	-$4.790M
YoY Change		546.25%	188.78%
Interest Expense	$630.0K	$2.344K	$9.408K
YoY Change	-6400.0%	-75.09%	-4.85%
% of Operating Profit
Other Income/Expense, Net	$0.00	-$485.7K	-$5.537K
YoY Change	-100.0%	8671.16%	-101.59%
Pretax Income	-$11.94M	-$31.44M	-$4.795M
YoY Change	290.2%	555.63%	266.22%
Income Tax	-$4.240M	-$1.533M	$15.44K
% Of Pretax Income
Net Earnings	-$8.830M	-$29.91M	-$4.795M
YoY Change	-111.35%	523.67%	261.95%
Net Earnings / Revenue	-314.23%	-651.25%	-532.17%
Basic Earnings Per Share			$1.68
Diluted Earnings Per Share	-$16.05M	-$57.52M	$1.67
COMMON SHARES
Basic Shares Outstanding	15.65M shares	15.42M shares	65.00M shares
Diluted Shares Outstanding			65.81M shares

Balance Sheet

Concept	2017 Q4	2017 Q3	2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.800M	$17.10M	$135.9M
YoY Change	203.45%	-87.42%	681.03%
Cash & Equivalents	$8.769M	$17.12M	$69.11M
Short-Term Investments			$66.80M
Other Short-Term Assets	$4.500M	$1.000M	$500.0K
YoY Change	1025.0%	100.0%	150.0%
Inventory
Prepaid Expenses
Receivables	$3.800M	$2.900M	$1.600M
Other Receivables	$6.400M	$5.100M	$0.00
Total Short-Term Assets	$23.47M	$26.12M	$138.0M
YoY Change	422.96%	-81.08%	656.55%
LONG-TERM ASSETS
Property, Plant & Equipment	$603.1K	$280.1K	$153.8K
YoY Change	239.11%	82.09%	-38.04%
Goodwill		$9.335M	$2.348M
YoY Change		297.49%	0.0%
Intangibles	$38.72M	$38.59M
YoY Change	158.93%
Long-Term Investments
YoY Change
Other Assets	$238.9K	$22.25K	$0.00
YoY Change	973.88%		-100.0%
Total Long-Term Assets	$39.56M	$48.22M	$2.502M
YoY Change	16.66%	1827.19%	-5.58%
TOTAL ASSETS
Total Short-Term Assets	$23.47M	$26.12M	$138.0M
Total Long-Term Assets	$39.56M	$48.22M	$2.502M
Total Assets	$63.03M	$74.35M	$140.5M
YoY Change	64.14%	-47.1%	572.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$129.1K	$495.1K	$614.5K
YoY Change	-93.56%	-19.44%	100.72%
Accrued Expenses	$3.661M	$3.600M	$2.000M
YoY Change	23.15%	80.0%	-4.76%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.840M	$4.180M	$3.728M
YoY Change	-29.81%	12.12%	56.61%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$600.0K	$0.00
YoY Change
Other Long-Term Liabilities	$160.0K	$4.200M	$427.1K
YoY Change	-63.85%	883.43%	-0.91%
Total Long-Term Liabilities	$160.0K	$4.800M	$427.1K
YoY Change	-63.85%	1023.92%	-0.91%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.840M	$4.180M	$3.728M
Total Long-Term Liabilities	$160.0K	$4.800M	$427.1K
Total Liabilities	$14.35M	$17.28M	$4.156M
YoY Change	131.75%	315.77%	28.91%
SHAREHOLDERS EQUITY
Retained Earnings	-$77.68M	-$68.85M	-$107.7M
YoY Change	148.52%	-36.05%	-51.61%
Common Stock	$61.00	$1.563K	$6.642K
YoY Change	-91.18%	-76.47%	-100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$39.40M	$48.83M	$136.4M
YoY Change
Total Liabilities & Shareholders Equity	$63.03M	$74.35M	$140.5M
YoY Change	64.14%	-47.1%	572.57%

Cashflow Statement

Concept	2017 Q4	2017 Q3	2016 Q3
OPERATING ACTIVITIES
Net Income	-$8.830M	-$29.91M	-$4.795M
YoY Change	-111.35%	523.67%	261.95%
Depreciation, Depletion And Amortization	$40.00K	$30.00K	$32.24K
YoY Change	100.0%	-6.93%	-7.91%
Cash From Operating Activities	-$4.800M	-$4.260M	-$12.04M
YoY Change	222.15%	-64.62%	805.26%
INVESTING ACTIVITIES
Capital Expenditures	-$30.00K	-$30.00K	-$150.0K
YoY Change	-25.0%	-80.0%	1400.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$10.00K	$0.00
YoY Change
Cash From Investing Activities	-$20.00K	-$20.00K	-$150.0K
YoY Change	-50.0%	-86.67%	1400.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	12.99M	5.230M
YoY Change	-100.0%	148.37%	1587.1%
NET CHANGE
Cash From Operating Activities	-4.800M	-4.260M	-12.04M
Cash From Investing Activities	-20.00K	-20.00K	-150.0K
Cash From Financing Activities	0.000	12.99M	5.230M
Net Change In Cash	-4.820M	8.710M	-6.960M
YoY Change	117.12%	-225.14%	575.73%
FREE CASH FLOW
Cash From Operating Activities	-$4.800M	-$4.260M	-$12.04M
Capital Expenditures	-$30.00K	-$30.00K	-$150.0K
Free Cash Flow	-$4.770M	-$4.230M	-$11.89M
YoY Change	228.97%	-64.42%	800.76%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	4658.000	shares
CY2016Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5103612
CY2016Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	612112	shares
CY2017Q3	us-gaap	Assets Current AssetsCurrent	26122474
CY2017Q2	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	1673695
CY2017Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	21014
CY2017Q3	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Carrying Amount RedeemableNoncontrollingInterestEquityPreferredCarryingAmount	6276228
CY2017Q3	alt	Number Of Installment NumberOfInstallment	9	Installments
CY2017Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	15652640	shares
CY2017Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.01
CY2017Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	49776	shares
CY2016Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	477613.000	shares
CY2017Q3	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	885549
CY2017Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	122392504
CY2017Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	495064
CY2017Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	2902503
CY2017Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4709973
CY2017Q3	us-gaap	Assets Assets	74346118
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17116845
CY2017Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17151019
CY2017Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2017Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2017Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15627081	shares
CY2017Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.70
CY2017Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2350085	shares
CY2017Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15652640	shares
CY2017Q3	us-gaap	Common Stock Value CommonStockValue	1563
CY2017Q3	us-gaap	Deferred Compensation Cashbased Arrangements Liability Classified Noncurrent DeferredCompensationCashbasedArrangementsLiabilityClassifiedNoncurrent	343
CY2017Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	19753
CY2017Q3	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	1591
CY2017Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	8312426
CY2017Q3	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	18626
CY2017Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	164609
CY2017Q3	us-gaap	Due To Officers Or Stockholders Noncurrent DueToOfficersOrStockholdersNoncurrent	81414
CY2017Q3	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	1070006
CY2017Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	472165
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	34781
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	320409
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	14222
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	48227
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	53027
CY2017Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	957088
CY2017Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	484923
CY2017Q3	us-gaap	Goodwill Goodwill	9334904
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	14257
CY2017Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	5061920
CY2017Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	536
CY2017Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	38586399
CY2017Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	39058564
CY2017Q3	us-gaap	Liabilities Liabilities	17277574
CY2017Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	74346118
CY2017Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4180458
CY2017Q3	us-gaap	Long Term Debt LongTermDebt	590185
CY2017Q3	us-gaap	Notes Payable Current NotesPayableCurrent	49702
CY2017Q3	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	4027962
CY2017Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	22248
CY2017Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1007032
CY2017Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	280093
CY2017Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	34174
CY2017Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-68853850
CY2017Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	857749
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	5.11
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	25991
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	748783	shares
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	883740
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	971221	shares
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1720004	shares
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.44
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.73
CY2017Q3	us-gaap	Stockholders Equity StockholdersEquity	48830244
CY2017Q3	alt	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	3597313
CY2017Q3	alt	Accrued Research And Development AccruedResearchAndDevelopment	1559808
CY2017Q3	alt	Class Of Warrant Or Right Grant Date Fair Value ClassOfWarrantOrRightGrantDateFairValue	3498720
CY2015Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4638711
CY2015Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	208.614	shares
CY2016Q4	us-gaap	Assets Current AssetsCurrent	4487090
CY2016Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	689135
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	71034899
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2005208
CY2016Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	383046
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-7574812
CY2016Q4	us-gaap	Assets Assets	38400335
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2876113
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2876113
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6917204	shares
CY2016Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	616770	shares
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6991749	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	692
CY2016Q4	us-gaap	Deferred Compensation Cashbased Arrangements Liability Classified Noncurrent DeferredCompensationCashbasedArrangementsLiabilityClassifiedNoncurrent	1001
CY2016Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	19753
CY2016Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	15914
CY2016Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	14388
CY2016Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	179424
CY2016Q4	us-gaap	Due To Officers Or Stockholders Noncurrent DueToOfficersOrStockholdersNoncurrent	606199
CY2016Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	957719
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	431756
CY2016Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	909454
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	477698
CY2016Q4	us-gaap	Goodwill Goodwill	18758421
CY2016Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	807507
CY2016Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	169790
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	14954717
CY2016Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	15386473
CY2016Q4	us-gaap	Liabilities Liabilities	6193012
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	38400335
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5470723
CY2016Q4	us-gaap	Long Term Debt LongTermDebt	525950
CY2016Q4	us-gaap	Notes Payable Current NotesPayableCurrent	458629
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	22248
CY2017Q3	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	2345427	shares
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	40409
	dei	Amendment Flag AmendmentFlag	false
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	420424
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	177859
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-31259449
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	32207323
CY2016Q4	alt	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	2972745
CY2016Q4	alt	Accrued Research And Development AccruedResearchAndDevelopment	549902
CY2017Q2	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	6883498	shares
CY2017Q2	us-gaap	Debt Instrument Convertible Number Of Equity Instruments DebtInstrumentConvertibleNumberOfEquityInstruments	316734	pure
CY2017Q2	alt	Discount Rate To Determine Present Value Of Cash Flow DiscountRateToDeterminePresentValueOfCashFlow	0.23	pure
CY2017Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	3498632
CY2017Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	1157
CY2017Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	19857
CY2017Q3	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	13018570
CY2017Q3	alt	Percentage Of Average Of Three Lowest Weightedaverage Prices Of Common Stock PercentageOfAverageOfThreeLowestWeightedaveragePricesOfCommonStock	0.85	pure
CY2017Q3	alt	Percentage Of Redeemable Preferred Shares To Be Redeemed PercentageOfRedeemablePreferredSharesToBeRedeemed	1.25	pure
CY2017Q3	alt	Late Charge Percentage Per Annum On Unpaid Amount LateChargePercentagePerAnnumOnUnpaidAmount	0.12	pure
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	548956
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1137125
	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	-3223853
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	905230
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	98060
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	14274906
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	13684535
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-40459240
	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	2395203	shares
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	3645424
	us-gaap	Decrease In Restricted Cash DecreaseInRestrictedCash	200000
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	548956
	us-gaap	Depreciation Depreciation	61191
	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	2125141
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-3.43
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Type DocumentType	10-Q
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	86879
	dei	Document Period End Date DocumentPeriodEndDate	2017-09-30
	dei	Entity Registrant Name EntityRegistrantName	ALTIMMUNE, INC.
	dei	Entity Central Index Key EntityCentralIndexKey	0001326190
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Accelerated Filer
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-3745
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	15573822
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	26600000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6863782
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	1602661
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-40120900
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	243056
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-14815
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	2142987
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	13754583
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-15407930
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-39719542
	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	Reporting_Unit
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1393988
	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	10085
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2526499
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2273397
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-34680
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	150524
	us-gaap	Interest Expense InterestExpense	160103
	us-gaap	Investment Income Interest InvestmentIncomeInterest	19538
	us-gaap	Interest Paid InterestPaid	5882
	us-gaap	License And Services Revenue LicenseAndServicesRevenue	36565
	us-gaap	Operating Expenses OperatingExpenses	47410185
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	15841374
	us-gaap	Net Income Loss NetIncomeLoss	-37594401
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	Segment
	us-gaap	Operating Income Loss OperatingIncomeLoss	-39480701
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-640199
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	2864839
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	2864839
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	9839
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	47634
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	89849
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	3018780
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	7531
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	13018570
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	16455
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	212431
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13946403
	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	231900
	us-gaap	Revenue From Grants RevenueFromGrants	7892919
	us-gaap	Sales Revenue Net SalesRevenueNet	7929484
	us-gaap	Share Based Compensation ShareBasedCompensation	1137125
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y11M4D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y4M28D
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	44742737
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y7M10D
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	16455
	dei	Trading Symbol TradingSymbol	ALT
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-1157
	us-gaap	Unrealized Gain Loss On Securities UnrealizedGainLossOnSecurities	-508316
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	11595698	shares
	alt	Number Of Warrants Exercised For Conversion Of Securities NumberOfWarrantsExercisedForConversionOfSecurities	661888	shares
	alt	Exchange Of Stock ExchangeOfStock	1-for-1 basis
	alt	Control Premium Percentage ControlPremiumPercentage	0.35	pure
	alt	Adjustments To Additional Paid In Capital Accretion Of Convertible Preferred Stock AdjustmentsToAdditionalPaidInCapitalAccretionOfConvertiblePreferredStock	1962072
	alt	Accrued Expenses And Conversion Of Note Payable To Convertible Notes AccruedExpensesAndConversionOfNotePayableToConvertibleNotes	1077540
	alt	Estimated Average Market Fair Value Of Intangible Assets EstimatedAverageMarketFairValueOfIntangibleAssets	36200000
	alt	Reporting Unit Carrying Amount ReportingUnitCarryingAmount	75430244
	alt	Stock Issued During Period Value Conversion Of Convertible Notes And Accrued Interest StockIssuedDuringPeriodValueConversionOfConvertibleNotesAndAccruedInterest	3645424
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	60552
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	584784
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1950159
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	464901
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13146066
	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	403498	shares
	us-gaap	Depreciation Depreciation	47276
	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	247562
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.20
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-170048
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5301444
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8024985
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-70705
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	371715
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	103308
	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	5971
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	925664
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	80668
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-67465
	us-gaap	Interest Expense InterestExpense	28858
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1047
	us-gaap	Interest Paid InterestPaid	2424
	us-gaap	License And Services Revenue LicenseAndServicesRevenue	168341
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-179347
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-4860116
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8272547
	us-gaap	Operating Expenses OperatingExpenses	10146489
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	5674412
	us-gaap	Net Income Loss NetIncomeLoss	-8024985
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7994574
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-30411
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	5121081
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2600
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	66307
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	113040
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	531
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	5673680
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	300
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	99
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4845045
	us-gaap	Revenue From Grants RevenueFromGrants	1983574
	us-gaap	Sales Revenue Net SalesRevenueNet	2151915
	us-gaap	Share Based Compensation ShareBasedCompensation	584784
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	6911366	shares
	alt	Preferred Stock Issuance Reclassified As Additional Paid In Capital PreferredStockIssuanceReclassifiedAsAdditionalPaidInCapital	325280
CY2016Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	195056
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6111846
CY2016Q3	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	134499	shares
CY2016Q3	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	104548
CY2016Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.71
CY2016Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3289647
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4795059
CY2016Q3	us-gaap	Interest Expense InterestExpense	9408
CY2016Q3	us-gaap	License And Services Revenue LicenseAndServicesRevenue	4938
CY2016Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4899607
CY2016Q3	us-gaap	Operating Expenses OperatingExpenses	5690561
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-4795059
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4789522
CY2016Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5537
CY2016Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	1316787
CY2016Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3871
CY2016Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2400914
CY2016Q3	us-gaap	Revenue From Grants RevenueFromGrants	896101
CY2016Q3	us-gaap	Sales Revenue Net SalesRevenueNet	901039
CY2016Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	6911715	shares
CY2017Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	453037
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-30933270
CY2017Q3	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	2345427	shares
CY2017Q3	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	1962072
CY2017Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.05
CY2017Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	26600000
CY2017Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3038756
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-31438027
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1532790
CY2017Q3	us-gaap	Interest Expense InterestExpense	2344
CY2017Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	15372
CY2017Q3	us-gaap	License And Services Revenue LicenseAndServicesRevenue	26689
CY2017Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-31867309
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	35544308
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-29905237
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-30952368
CY2017Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-485659
CY2017Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	1028033
CY2017Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	10786
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5905552
CY2017Q3	us-gaap	Revenue From Grants RevenueFromGrants	4565251
CY2017Q3	us-gaap	Sales Revenue Net SalesRevenueNet	4591940
CY2017Q3	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-1157
CY2017Q3	us-gaap	Unrealized Gain Loss On Securities UnrealizedGainLossOnSecurities	-508316
CY2017Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	15527867	shares

Files In Submission

Name	View Source	Status
0001193125-17-338977-index-headers.html	Edgar Link	pending
0001193125-17-338977-index.html	Edgar Link	pending
0001193125-17-338977.txt	Edgar Link	pending
0001193125-17-338977-xbrl.zip	Edgar Link	pending
alt-20170930.xml	Edgar Link	completed
alt-20170930.xsd	Edgar Link	pending
alt-20170930_cal.xml	Edgar Link	unprocessable
alt-20170930_def.xml	Edgar Link	unprocessable
alt-20170930_lab.xml	Edgar Link	unprocessable
alt-20170930_pre.xml	Edgar Link	unprocessable
d457143d10q.htm	Edgar Link	pending
d457143dex103.htm	Edgar Link	pending
d457143dex104.htm	Edgar Link	pending
d457143dex311.htm	Edgar Link	pending
d457143dex312.htm	Edgar Link	pending
d457143dex321.htm	Edgar Link	pending
d457143dex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ALT
Altimmune, Inc. Stock $alt

2017 Q4 Form 10-Q Financial Statement

#000119312517338977 Filed on November 09, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALT Altimmune, Inc. Stock $alt

2017 Q4 Form 10-Q Financial Statement

#000119312517338977 Filed on November 09, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALT
Altimmune, Inc. Stock $alt